The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights the key company collaborations in pharma to advance AI-powered drug repurposing techniques.
~96% decline reported in Malaria cases in Madhya Pradesh, due to public-private-people partnership
This includes USD 100 million to advance R&D of its neglected tropical disease program, focusing on novel drug candidates for four diseases.
The company will invest approximately €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at Blarney Business Park, both in Cork, Ireland
The mRNA vaccine candidate is fully indigenous and devoid of any technology contributions from elsewhere
Center of Excellence for Molecular Diagnostics and Proteomics will enable affordable diagnostics for infectious diseases in India
It is a point-of-care portable, battery-operated, IoT-enabled platform with a sample to result in less than 1 hour
.jpg)
Molbio Diagnostics has been the pioneer in providing access to molecular testing through its Truenat Real Time PCR platform. Sriram Natarajan, Director & CEO, of the company shares his experiences on the journey so far in an interview with Thomas C Thottathil
The rates for over 400 procedures were revised
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
